Product Information
METOCLOPRAMIDE 10 MG/2 ML VIAL is a generic product labeled by Avenacy Inc., priced at $0.5290 per ML under NDC 83634077902. Its NADAC has been published 99 times since Nov 13, 2024.
FDA first approved this application on Dec 20, 2013. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Avenacy Inc.NDC
83634077902
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
7/22/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204756FDA Approved
12/20/2013
TE Code
AP
On Market Since
6/30/2024
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has been published 99 times since Nov 13, 2024, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5290 per ML |
|---|---|
| All-time high | $0.6016 (May 14, 2025) |
| All-time low | $0.5162 (May 21, 2025) |
| 52-week high | $0.5732 |
| 52-week low | $0.5178 |
| Median price | $0.5654 |
| Average price | $0.5582 |
| Largest weekly change | -14.2% (May 21, 2025) |
| Weeks tracked | 99 |
| Tracking since | Nov 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the metoclopramide hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Avenacy Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metoclopramide hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dopamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 10 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG/2 ML VIAL, manufactured by Avenacy Inc., is $0.5290 per ML (NDC 83634077902), effective Sep 30, 2026.
How has the price of METOCLOPRAMIDE 10 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has declined 12.1%. It has been tracked across 99 weekly CMS publications since Nov 13, 2024.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG/2 ML VIAL?
Since Nov 13, 2024, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has ranged from a low of $0.5162 (May 21, 2025) to a high of $0.6016 (May 14, 2025), with a median of $0.5654 per ML.
Are there cheaper alternatives to METOCLOPRAMIDE 10 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of METOCLOPRAMIDE 10 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METOCLOPRAMIDE 10 MG/2 ML VIAL?
METOCLOPRAMIDE 10 MG/2 ML VIAL (NDC 83634077902) is labeled by Avenacy Inc., and CMS classifies it as a generic product.